Stocks-Prognosis.com
Search on StockPrognosis.com
To search on the site stockprognosis.com enter the name of the ticker, company name, or search phrase
Sections of the site



Eli Lilly and Co LLY Traded Lower in Q2 Despite Good Results

August 12, 2025
Eli Lilly and Company, despite reporting good results in the second quarter of this year, saw its stock price traded lower. The pharmaceutical giant had a strong performance, with Mounjaro Zepbound sales soaring, but this did not seem to impress investors. As the company hiked its 2025 outlook and topped quarterly estimates, the market still reacted negatively. Analysts suggest that this dip may present a buying opportunity for those interested in investing in LLY stock.
If you want to leave a comment, then you need Login or Register





Other data for LLY

Related data

LLYAugust 1, 2025Eli Lilly and Company Completes Acquisition of Verve Therapeutics, Advancing One-Time Treatments for High Cardiovascular Risk  ~1 min.

Eli Lilly and Company has announced the successful completion of its acquisition of Verve Therapeutics, a move that will help advance innovative one-time treatments for individuals with high cardiovascular risk. This strategic decision showcases the company's commitment to revolutionizing the healthcare industry and improving patient outcomes. Investors are eagerly watching as Eli Lilly continues ...


LLYJuly 20, 2025Strong Q2 Forecast for ELI LILLY AND COMPANY by J.P. Morgan  ~1 min.

According to J.P. Morgan, Eli Lilly and Company is expected to have a strong second quarter performance. The pharmaceutical giant has been receiving positive attention from investors and analysts alike....


LLYMarch 22, 2025Eli Lilly and Company LLY: Leading the Way in Pharmaceutical Innovation  ~2 min.

Eli Lilly and Company (LLY) continues to make waves in the pharmaceutical industry with its innovative and groundbreaking therapies....


LLYMarch 19, 2025Eli Lilly and Company LLY Surges After Breakthrough BRAVE-AA-PEDS Study Results  ~2 min.

Eli Lilly and Company (LLY) has recently made a significant breakthrough in its BRAVE-AA-PEDS study, resulting in a surge of investor attention and market gains....


LLYMarch 18, 2025Eli Lilly and Company: A Promising Investment in the Pharma Industry  ~1 min.

Eli Lilly and Company (LLY) has been making waves in the pharmaceutical industry with its innovative products and strong performance....


LLYMarch 17, 2025Eli Lilly and Company's Groundbreaking Discovery Revolutionizes Pharma Industry  ~2 min.

Eli Lilly and Company, a renowned pharmaceutical giant, has recently made a groundbreaking discovery that is set to revolutionize the entire industry....


LLYMarch 16, 2025Is Eli Lilly and Company LLY Set to Revolutionize the Pharma Industry?  ~2 min.

Eli Lilly and Company (LLY) has been making headlines recently with its groundbreaking research and innovative products....


LLYMarch 14, 2025Eli Lilly and Company Reports Promising Results in Hair Regrowth Study  ~1 min.

Eli Lilly and Company (LLY) recently announced the positive outcome of their Phase 3 clinical trial for baricitinib, a drug aimed at treating severe alopecia areata in adolescents....


LLYFebruary 28, 2025Lilly plans to more than double U.S. manufacturing investment since 2020 exceeding 50 billion  ~1 min.

Eli Lilly and Company (LLY) is set to significantly increase its manufacturing investment in the United States, surpassing a staggering 50 billion since 2020....


LLYFebruary 27, 2025Eli Lilly and Company Acquires Organovos FXR Program in IBD Treatment Development  ~1 min.

Eli Lilly and Company has recently made headlines with its acquisition of Organovos FXR Program, a significant step towards advancing treatment options for Inflammatory Bowel Disease (IBD)....


JNJJanuary 5, 2025Johnson & Johnson Reports Decline in Short Interest, Declares Dividend  ~1 min.

Johnson & Johnson, a multinational pharmaceutical company, recently declared its quarterly dividend and reported a decline in short interest....


NVOMarch 4, 2024NOVO NORDISK A/S Hits Price Target Forecast on QuantWave with 34.42% Profit  ~1 min.

NOVO NORDISK A/S, a leading pharmaceutical company, has seen its stock price reach the forecasted target on QuantWave, yielding a profit of 34.42%....


JNJJanuary 8, 2025Johnson & Johnson Reports Strong Quarterly Earnings  ~2 min.

Johnson & Johnson (JNJ) announced its quarterly earnings today, showcasing impressive growth and beating analysts' expectations. The company reported a revenue of $22....


The Smartest Dividend Stocks to Buy With $1000 Right Now  ~3 min.

Investing in dividend stocks can be a great way to generate passive income and potentially grow your wealth over time....


ZTSApril 8, 2025QuantWave Successfully Forecasts ZOETIS INC. Stock with 12.49% Profit  ~1 min.

QuantWave, the automated forecasting platform, has once again proven its efficacy by accurately predicting the price movement of ZOETIS INC. stock....